Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Veit

Showing results (141-150 of 236) with videos related to

Pageof 24
Sort By:
European Radiology|May 29, 2015
PET/MRI and PET/CT in advanced gynaecological tumours: initial experience and comparisonMarcelo A Queiroz, Rahel A Kubik-Huch, Nik Hauser, et al.
EJNMMI Research|January 24, 2014
Multiparametric PET/CT-perfusion does not add significant additional information for initial staging in lung cancer compared with standard PET/CTMartin W Huellner, Timothy D Collen, Philipp Gut, et al.
Medical Physics|February 5, 2019
Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MRDiem Vuong, Stephanie Tanadini-Lang, Martin W Huellner, et al.
Tomography (Ann Arbor, Mich.)|September 27, 2024
<sup>18</sup>F-Fluoroazomycin Arabinoside (FAZA) PET/MR as a Biomarker of Hypoxia in Rectal Cancer: A Pilot StudyUr Metser, Andres Kohan, Catherine O'Brien, et al.
Scientific Reports|November 11, 2025
Added prognostic value of baseline pre-infusion <sup>18</sup>F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapySeyed Ali Mirshahvalad, Andres Kohan, Roshini Kulanthaivelu, et al.
Radiology|September 16, 2017
Reduction of <sup>18</sup>F-FDG Dose in Clinical PET/MR Imaging by Using Silicon Photomultiplier DetectorsTetsuro Sekine, Gaspar Delso, Konstantinos G Zeimpekis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 5, 2014
Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?Felix P Kuhn, Martin Hüllner, Caecilia E Mader, et al.
Scientific Reports|January 28, 2026
Correction: Added prognostic value of baseline pre-infusion <sup>18</sup>F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapySeyed Ali Mirshahvalad, Andres Kohan, Roshini Kulanthaivelu, et al.
Clinical Imaging|August 30, 2014
Integrated CT-perfusion shows no meaningful correlation with PSA and presurgical Gleason score in patients with early prostate cancerMartin W Huellner, Agostino Mattei, Steffen Ross, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2021
Quantitative <sup>68</sup>Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy Response in Patients with Progressive Metastatic Neuroendocrine Tumors Treated with <sup>177</sup>Lu-DOTATATEClaudia Ortega, Rebecca K S Wong, Josh Schaefferkoetter, et al.
Pageof 24

Showing results (141-150 of 236) with videos related to

Sort By:
Pageof 24
European Radiology|May 29, 2015
PET/MRI and PET/CT in advanced gynaecological tumours: initial experience and comparisonMarcelo A Queiroz, Rahel A Kubik-Huch, Nik Hauser, et al.
EJNMMI Research|January 24, 2014
Multiparametric PET/CT-perfusion does not add significant additional information for initial staging in lung cancer compared with standard PET/CTMartin W Huellner, Timothy D Collen, Philipp Gut, et al.
Medical Physics|February 5, 2019
Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MRDiem Vuong, Stephanie Tanadini-Lang, Martin W Huellner, et al.
Tomography (Ann Arbor, Mich.)|September 27, 2024
<sup>18</sup>F-Fluoroazomycin Arabinoside (FAZA) PET/MR as a Biomarker of Hypoxia in Rectal Cancer: A Pilot StudyUr Metser, Andres Kohan, Catherine O'Brien, et al.
Scientific Reports|November 11, 2025
Added prognostic value of baseline pre-infusion <sup>18</sup>F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapySeyed Ali Mirshahvalad, Andres Kohan, Roshini Kulanthaivelu, et al.
Radiology|September 16, 2017
Reduction of <sup>18</sup>F-FDG Dose in Clinical PET/MR Imaging by Using Silicon Photomultiplier DetectorsTetsuro Sekine, Gaspar Delso, Konstantinos G Zeimpekis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 5, 2014
Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?Felix P Kuhn, Martin Hüllner, Caecilia E Mader, et al.
Scientific Reports|January 28, 2026
Correction: Added prognostic value of baseline pre-infusion <sup>18</sup>F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapySeyed Ali Mirshahvalad, Andres Kohan, Roshini Kulanthaivelu, et al.
Clinical Imaging|August 30, 2014
Integrated CT-perfusion shows no meaningful correlation with PSA and presurgical Gleason score in patients with early prostate cancerMartin W Huellner, Agostino Mattei, Steffen Ross, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2021
Quantitative <sup>68</sup>Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy Response in Patients with Progressive Metastatic Neuroendocrine Tumors Treated with <sup>177</sup>Lu-DOTATATEClaudia Ortega, Rebecca K S Wong, Josh Schaefferkoetter, et al.
Pageof 24